tiprankstipranks
Trending News
More News >
Universal Health (UHS)
NYSE:UHS
US Market
Advertisement

Universal Health (UHS) Ratios

Compare
498 Followers

Universal Health Ratios

UHS's free cash flow for Q1 2025 was $0.11. For the 2025 fiscal year, UHS's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.32 1.40 1.33 1.14 1.32
Quick Ratio
1.23 1.29 1.21 1.04 1.25
Cash Ratio
0.05 0.06 0.05 0.06 0.49
Solvency Ratio
0.22 0.17 0.17 0.22 0.21
Operating Cash Flow Ratio
0.87 0.63 0.52 0.45 0.95
Short-Term Operating Cash Flow Coverage
17.46 6.39 6.67 7.83 6.02
Net Current Asset Value
$ -4.91B$ -4.95B$ -4.99B$ -4.63B$ -3.79B
Leverage Ratios
Debt-to-Assets Ratio
0.34 0.38 0.39 0.35 0.31
Debt-to-Equity Ratio
0.74 0.87 0.89 0.75 0.66
Debt-to-Capital Ratio
0.43 0.47 0.47 0.43 0.40
Long-Term Debt-to-Capital Ratio
0.40 0.43 0.44 0.40 0.35
Financial Leverage Ratio
2.16 2.27 2.28 2.15 2.13
Debt Service Coverage Ratio
6.81 3.80 5.19 8.25 3.15
Interest Coverage Ratio
10.02 5.81 7.91 16.29 12.78
Debt to Market Cap
0.40 0.47 0.47 0.39 0.33
Interest Debt Per Share
81.09 80.33 73.83 56.27 50.56
Net Debt to EBITDA
2.12 3.01 3.15 2.31 1.59
Profitability Margins
Gross Profit Margin
58.43%89.27%89.00%88.71%88.86%
EBIT Margin
10.91%8.04%7.38%10.89%11.75%
EBITDA Margin
14.57%12.21%12.26%15.25%16.18%
Operating Profit Margin
10.87%8.23%7.49%10.78%11.75%
Pretax Profit Margin
9.84%6.58%6.46%10.23%10.83%
Net Profit Margin
7.44%5.03%5.04%7.84%8.17%
Continuous Operations Profit Margin
7.58%5.04%4.90%7.81%8.24%
Net Income Per EBT
75.65%76.33%77.99%76.67%75.39%
EBT Per EBIT
90.53%80.01%86.32%94.88%92.18%
Return on Assets (ROA)
8.05%5.14%5.01%7.57%7.00%
Return on Equity (ROE)
17.92%11.67%11.41%16.28%14.94%
Return on Capital Employed (ROCE)
13.93%9.83%8.67%12.27%12.35%
Return on Invested Capital (ROIC)
10.63%7.35%6.45%9.22%9.03%
Return on Tangible Assets
10.95%7.15%7.05%10.86%9.84%
Earnings Yield
10.04%6.79%6.56%9.27%8.07%
Efficiency Ratios
Receivables Turnover
6.67 6.38 6.64 7.24 6.69
Payables Turnover
0.76 2.50 2.32 2.17 2.26
Inventory Turnover
7.15 7.06 6.75 6.90 6.76
Fixed Asset Turnover
2.26 2.18 2.10 2.03 2.02
Asset Turnover
1.08 1.02 0.99 0.97 0.86
Working Capital Turnover Ratio
23.78 20.10 29.70 23.41 20.04
Cash Conversion Cycle
-375.44 -37.33 -48.54 -65.19 -53.11
Days of Sales Outstanding
54.73 57.20 54.96 50.43 54.60
Days of Inventory Outstanding
51.05 51.67 54.10 52.90 53.96
Days of Payables Outstanding
481.22 146.20 157.60 168.52 161.66
Operating Cycle
105.78 108.87 109.06 103.33 108.55
Cash Flow Ratios
Operating Cash Flow Per Share
31.26 18.29 13.62 10.71 27.75
Free Cash Flow Per Share
16.26 7.57 3.58 0.34 19.12
CapEx Per Share
15.00 10.72 10.04 10.37 8.63
Free Cash Flow to Operating Cash Flow
0.52 0.41 0.26 0.03 0.69
Dividend Paid and CapEx Coverage Ratio
1.98 1.59 1.26 0.96 3.14
Capital Expenditure Coverage Ratio
2.08 1.71 1.36 1.03 3.21
Operating Cash Flow Coverage Ratio
0.40 0.24 0.19 0.19 0.56
Operating Cash Flow to Sales Ratio
0.13 0.09 0.07 0.07 0.20
Free Cash Flow Yield
8.94%4.97%2.54%0.26%13.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
9.96 14.72 15.25 10.79 12.39
Price-to-Sales (P/S) Ratio
0.73 0.74 0.77 0.85 1.01
Price-to-Book (P/B) Ratio
1.73 1.72 1.74 1.76 1.85
Price-to-Free Cash Flow (P/FCF) Ratio
11.19 20.14 39.32 381.63 7.19
Price-to-Operating Cash Flow Ratio
5.87 8.34 10.34 12.11 4.96
Price-to-Earnings Growth (PEG) Ratio
1.76 1.21 -0.66 1.35 0.59
Price-to-Fair Value
1.73 1.72 1.74 1.76 1.85
Enterprise Value Multiple
7.16 9.07 9.42 7.86 7.84
Enterprise Value
16.79B 15.81B 15.47B 15.14B 14.67B
EV to EBITDA
7.16 9.07 9.42 7.86 7.84
EV to Sales
1.04 1.11 1.15 1.20 1.27
EV to Free Cash Flow
15.89 30.14 59.04 540.15 9.02
EV to Operating Cash Flow
8.27 12.47 15.53 17.14 6.21
Tangible Book Value Per Share
45.21 31.63 27.11 26.11 28.70
Shareholders’ Equity Per Share
105.78 88.70 80.97 73.80 74.27
Tax and Other Ratios
Effective Tax Rate
0.23 0.24 0.24 0.24 0.24
Revenue Per Share
247.56 206.03 183.26 153.20 135.89
Net Income Per Share
18.42 10.35 9.24 12.02 11.10
Tax Burden
0.76 0.76 0.78 0.77 0.75
Interest Burden
0.90 0.82 0.88 0.94 0.92
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.48 0.51 0.51 0.50 0.50
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.66 1.77 1.52 0.89 2.48
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis